Pfiz­er brings In­di­an gener­ics mak­er to court over Xel­janz patent

Pfiz­er filed suit against an In­di­an phar­ma­ceu­ti­cal com­pa­ny on Fri­day over its ap­pli­ca­tion to mar­ket gener­ic ver­sions of Xel­janz XR.

Xel­janz XR is an ex­tend­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER